WO2008035086A3 - Synthesis of leukotriene compounds - Google Patents

Synthesis of leukotriene compounds Download PDF

Info

Publication number
WO2008035086A3
WO2008035086A3 PCT/GB2007/003581 GB2007003581W WO2008035086A3 WO 2008035086 A3 WO2008035086 A3 WO 2008035086A3 GB 2007003581 W GB2007003581 W GB 2007003581W WO 2008035086 A3 WO2008035086 A3 WO 2008035086A3
Authority
WO
WIPO (PCT)
Prior art keywords
leukotriene
synthesis
compounds
present
montelukast
Prior art date
Application number
PCT/GB2007/003581
Other languages
French (fr)
Other versions
WO2008035086A2 (en
Inventor
Jonathan Wiffen
Ian Wilson
Original Assignee
Almac Sciences Ltd
Jonathan Wiffen
Ian Wilson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almac Sciences Ltd, Jonathan Wiffen, Ian Wilson filed Critical Almac Sciences Ltd
Publication of WO2008035086A2 publication Critical patent/WO2008035086A2/en
Publication of WO2008035086A3 publication Critical patent/WO2008035086A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/36Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/31Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to the synthesis of leukotriene receptor agonist compounds and to novel intermediates employed in their preparation. Leukotriene agonists are used in the treatment of asthma, as well as other conditions mediated by leukotrienes such as inflammation and allergies. A compound of particular interest is montelukast and the present invention describes an improved process for making montelukast and similar compounds.
PCT/GB2007/003581 2006-09-22 2007-09-21 Synthesis of leukotriene compounds WO2008035086A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0618703.3A GB0618703D0 (en) 2006-09-22 2006-09-22 Synthesis of leikotriene compounds
GB0618703.3 2006-09-22

Publications (2)

Publication Number Publication Date
WO2008035086A2 WO2008035086A2 (en) 2008-03-27
WO2008035086A3 true WO2008035086A3 (en) 2008-06-26

Family

ID=37421455

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2007/003581 WO2008035086A2 (en) 2006-09-22 2007-09-21 Synthesis of leukotriene compounds

Country Status (2)

Country Link
GB (1) GB0618703D0 (en)
WO (1) WO2008035086A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008510840A (en) 2005-07-05 2008-04-10 テバ ファーマシューティカル インダストリーズ リミティド Purification of Montelukast
CN104109123B (en) * 2013-04-16 2016-12-07 浙江奥翔药业股份有限公司 For midbody compound synthesizing montelukast and preparation method thereof
CN103288695B (en) * 2013-06-18 2016-01-13 成都迈斯克医药科技有限公司 The preparation method of 1-thiopurine methyltransferase cyclopropaneacetic acid
CN104592111B (en) * 2015-02-13 2015-11-11 江苏欧信医药化工有限公司 A kind of synthetic method of montelukast sodium intermediate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0480717A1 (en) * 1990-10-12 1992-04-15 Merck Frosst Canada Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
WO1995018107A1 (en) * 1993-12-28 1995-07-06 Merck & Co., Inc. Process for the preparation of leukotriene antagonists
US5523477A (en) * 1995-01-23 1996-06-04 Merck & Co., Inc. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0480717A1 (en) * 1990-10-12 1992-04-15 Merck Frosst Canada Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
WO1995018107A1 (en) * 1993-12-28 1995-07-06 Merck & Co., Inc. Process for the preparation of leukotriene antagonists
US5523477A (en) * 1995-01-23 1996-06-04 Merck & Co., Inc. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GRAUL L ET AL: "Montelukast sodium, MK-476, MK-0476, L-706631, Singulair", DRUGS OF THE FUTURE, BARCELONA, ES, vol. 22, no. 10, 1997, pages 1103, XP008082254, ISSN: 0377-8282 *
LABELLE M ET AL: "Discovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enxyme induction", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 5, no. 3, 2 February 1995 (1995-02-02), pages 283 - 288, XP004817884, ISSN: 0960-894X *

Also Published As

Publication number Publication date
WO2008035086A2 (en) 2008-03-27
GB0618703D0 (en) 2006-11-01

Similar Documents

Publication Publication Date Title
WO2007041077A3 (en) Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
WO2011149999A3 (en) Method for preparing antibodies having improved properties
WO2009095933A3 (en) Improved and novel process for the preparation of bosentan
WO2010049454A3 (en) Antimicrobial composition from copepods
WO2007041076A3 (en) 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
WO2007041112A3 (en) Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
WO2006087143A8 (en) Novel processes for the preparation of a 2h-chromene
WO2009104021A3 (en) Novel polymorphs and processes for their preparation
WO2008139452A3 (en) Selective bromination of perylene diimides and derivatives thereof under mild conditions
WO2008032099A3 (en) Process for the preparation of montelukast, and intermediates therefor
MA31834B1 (en) 5 - [(3,3,3-TRIFLUORO-2-HYDROXY-1-ARYLPROPYL) AMINO] -1H-QUINOLIN-2-ONES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE AS ANTI-INFLAMMATORY
WO2009068463A3 (en) Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates
WO2008035086A3 (en) Synthesis of leukotriene compounds
WO2007132354A3 (en) Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof
WO2009004643A3 (en) An improved process for preparation of (s)-pregabalin and intermediates thereof
WO2007047671A3 (en) Tetrahydroquinolines, synthesis thereof, and intermediates thereto
WO2010004578A3 (en) Novel and improved processes for the preparation of paliperidone
WO2008065282A3 (en) Substituted pyrazoles, compositions containing these, method of production and use
WO2012029077A3 (en) Process for preparing fluticasone propionate/furoate
MX2010001864A (en) Method for the preparation of montelukast acid in ionic liquid medium.
WO2009009122A3 (en) Derivatives of urea and related diamines, methods for their manufacture, and uses therefor
WO2008033935A3 (en) Vinorelbine derivatives
WO2007137098A3 (en) Sulfonyl-substituted bicyclic compounds as modulators of ppar
WO2009061875A3 (en) Processes and intermediates for producing aminobenzimidazole ureas
WO2010079506A3 (en) Pharmaceutical composition of aripiprazole

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07823912

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07823912

Country of ref document: EP

Kind code of ref document: A2